USPTO serial 79382067
NDURE
Reviewed by CopyMark Law Group
Status 622
- Filing date
- —
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- UNKNOWN
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NDURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations; biological preparations for medical purposes; diagnostic preparations and materials; therapeutic preparations and substances; anti-angiogenesis preparations; anti-cancer preparations; anti-inflammatory preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, physiological disorders, hormonal disorders, inherited disease, single gene disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, peripheral neurological disorders, genitourinary disorders, musculoskeletal disorders, and blood disorders; diagnostic reagents for medical use; DNA, antibodies and proteins for medical use; DNA and/or antibodies and/or proteins that stimulate cells for medical use; DNA, antibodies and proteins for therapeutic use; diagnostic products and reagents for medical use | ACTIVE | — |
| 042 | Medical and pharmacological research services; scientific and technological services and research and design relating thereto; scientific research for medical purposes; pharmaceutical research and development services; pharmaceutical testing; research and development in the biotechnology field; research and development services in the field of antibodies; biotechnology services; conducting clinical trials; biological research, clinical research and medical research; providing information about the results of clinical trials for pharmaceutical products; analytic and diagnostic research and laboratory services in the field of science; development of assays, both for products and analysis, provided for others; laboratory services; research and development of new products for others; research and scientific analysis relating to drug discovery, as well as development thereof for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research; provision of information and consultancy in relation to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 2, 2024 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Nov 11, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2023 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |